Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Iro, Heinrich
2009.
Handbuch HNO 2009.
p.
355.
Knecht, Rainald
2009.
Handbuch HNO 2009.
p.
311.
Sharon, Elad
Kelly, Ronan J
and
Szabo, Eva
2010.
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.
Head & Neck Oncology,
Vol. 2,
Issue. 1,
Grünbaum, M.
Ervens, J.
Stein, H.
and
Loddenkemper, C.
2010.
Primäres duktales Adenokarzinom im Bereich der Orbita.
Der Pathologe,
Vol. 31,
Issue. 4,
p.
279.
Taniguchi, Zenchi
Iguchi, Fukuichiro
Takahashi, Yuka
and
Murai, Norihiko
2011.
A Case of Parotid Gland Salivary Duct Carcinoma with HER-2 Protein Overexpression.
Practica Oto-Rhino-Laryngologica,
Vol. 104,
Issue. 1,
p.
33.
Jaspers, Heidy C.J.
Verbist, Berit M.
Schoffelen, Rafke
Mattijssen, Vera
Slootweg, Piet J.
van der Graaf, Winette T.A.
and
van Herpen, Carla M.L.
2011.
Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options.
Journal of Clinical Oncology,
Vol. 29,
Issue. 16,
p.
e473.
Suzuki, Takayoshi
Kano, Satoshi
Oridate, Nobuhiko
Honma, Akihiro
Suzuki, Seigo
Hatakeyama, Hiromitsu
Mizumachi, Takatsugu
Furusawa, Jun
Sakashita, Tomohiro
and
Fukuda, Satoshi
2011.
HER2 expression in salivary duct carcinoma.
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY,
Vol. 21,
Issue. 2,
p.
195.
Clauditz, Till Sebastian
Reiff, Maren
Gravert, Linn
Gnoss, Alexander
Tsourlakis, Maria-Christina
Münscher, Adrian
Sauter, Guido
Bokemeyer, Carsten
Knecht, Rainald
and
Wilczak, Waldemar
2011.
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Pathology,
Vol. 43,
Issue. 5,
p.
459.
Lagha, Aymen
Chraiet, Nesrine
Ayadi, Mouna
Krimi, Sarra
Allani, Bassem
Rifi, Hela
Raies, Henda
and
Mezlini, Amel
2012.
Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Head & Neck Oncology,
Vol. 4,
Issue. 1,
Wee, D T H
Thomas, A A
and
Bradley, P J
2012.
Salivary duct carcinoma: what is already known, and can we improve survival?.
The Journal of Laryngology & Otology,
Vol. 126,
Issue. S2,
p.
S2.
Lagha, Aymen
Chraiet, Nesrine
Ayadi, Mouna
Krimi, Sarra
Allani, Bassem
Rifi, Hela
Raies, Henda
and
Mezlini, Amel
2012.
RETRACTED: Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Oral Oncology,
Vol. 48,
Issue. 10,
p.
948.
Kim, J Y
Lee, S
Cho, K-J
Kim, S Y
Nam, S Y
Choi, S-H
Roh, J-L
Choi, E K
Kim, J H
Song, S Y
Shin, H S
Chang, S-K
and
Ahn, S D
2012.
Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.
The British Journal of Radiology,
Vol. 85,
Issue. 1018,
p.
e947.
Hiwatashi, Nao
Takebayashi, Shinji
Suzuki, Chiaki
Miyoshi, Takushi
Ikeda, Hiroki
and
Miura, Makoto
2012.
Salivary duct carcinoma in the submandibular gland with HER-2 protein overexpression: A report of two cases.
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY,
Vol. 22,
Issue. 3,
p.
327.
Hashimoto, Kazuki
Yamamoto, Hidetaka
Shiratsuchi, Hideki
Nakashima, Torahiko
Tamiya, Sadafumi
Nishiyama, Ken‐ichi
Higaki, Yuichiro
Komune, Shizuo
Tsuneyoshi, Masazumi
and
Oda, Yoshinao
2012.
HER‐2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in‐situ hybridization study.
Histopathology,
Vol. 60,
Issue. 6B,
Nardi, Valentina
Sadow, Peter M.
Juric, Dejan
Zhao, Dave
Cosper, Arjola K.
Bergethon, Kristin
Scialabba, Vanessa L.
Batten, Julie M.
Borger, Darrell R.
Iafrate, Anthony John
Heist, Rebecca S.
Lawrence, Donald P.
Flaherty, Keith T.
Bendell, Johanna C.
Deschler, Daniel
Li, Yi
Wirth, Lori J.
and
Dias-Santagata, Dora
2013.
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment.
Clinical Cancer Research,
Vol. 19,
Issue. 2,
p.
480.
Otsuka, Kuninori
Imanishi, Yorihisa
Habu, Noboru
Sato, Yoichiro
Shigetomi, Seiji
Fujii, Ryoichi
Sakamoto, Koji
Tomita, Toshiki
Fujii, Masato
Kameyama, Kaori
and
Ogawa, Kaoru
2013.
Survival Analysis and Immunohistochemical Study of HER-2 and AR (Androgen Receptor) Expression in Salivary Duct Carcinoma.
Nippon Jibiinkoka Gakkai Kaiho,
Vol. 116,
Issue. 9,
p.
1024.
Griffith, Christopher C.
Seethala, Raja R.
Luvison, Alyssa
Miller, Megan
and
Chiosea, Simion I.
2013.
PIK3CA Mutations and PTEN Loss in Salivary Duct Carcinomas.
American Journal of Surgical Pathology,
Vol. 37,
Issue. 8,
p.
1201.
Kadowaki, Shigenori
Yatabe, Yasushi
Hirakawa, Hitoshi
Komori, Azusa
Kondoh, Chihiro
Hasegawa, Yasuhisa
and
Muro, Kei
2013.
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.
Case Reports in Oncology,
Vol. 6,
Issue. 3,
p.
450.
Salovaara, Elina
Hakala, Olli
Bäck, Leif
Koivunen, Petri
Saarilahti, Kauko
Passador-Santos, Fabricio
Leivo, Ilmo
and
Mäkitie, Antti A.
2013.
Management and outcome of salivary duct carcinoma in major salivary glands.
European Archives of Oto-Rhino-Laryngology,
Vol. 270,
Issue. 1,
p.
281.
Krishnamurthy, Jairam
Krishnamurty, Devi Mukkai
Baker, John J.
Zhen, Weining
Lydiatt, Daniel
and
Ganti, Apar Kishor
2013.
Salivary duct carcinoma responding to trastuzumab‐based therapy: Case report and review of the literature.
Head & Neck,
Vol. 35,
Issue. 12,